Chenrezig Fund Inc
Madison, Wisconsin
CHealth Score
43C
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Below Average
๐ฐ
$125K
Total Revenue
๐
$137K
Total Expenses
๐ฆ
$58K
Net Assets
๐
N/A
Total Liabilities
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Revenue Growth
-21.5%
Year-over-year change (2022 โ 2023)
Net Margin
-9.9%
Revenue minus expenses as % of revenue
Filing History
13 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $124,782โ22% | $137,107โ44% | $57,768โ18% | |
| 2022 | $158,958โ15% | $95,061โ35% | $70,093โ1041% | โ |
| 2021 | $138,293โ36% | $147,236โ63% | $6,145โ59% | โ |
| 2020 | $101,847โ2% | $90,150โ25% | $15,088โ647% | โ |
| 2019 | $104,182โ17% | $120,165โ33% | $2,021โ89% | โ |
| 2018 | $89,280โ12% | $90,094โ12% | $18,004โ4% | โ |
| 2017 | $101,466โ71% | $101,960โ95% | $18,818โ3% | โ |
| 2016 | $59,457โ46% | $52,155โ54% | $19,333โ45% | โ |
| 2015 | $110,692โ60% | $114,217โ6% | $13,371โ21% | โ |
| 2014 | $69,365โ32% | $107,696โ2% | $16,896โ69% | โ |
| 2013 | $102,753โ13% | $105,077โ4% | $55,227โ4% | โ |
| 2012 | $90,884โ14% | $109,066โ14% | $57,550โ24% | โ |
| 2011 | $105,844 | $127,438 | $75,732 | โ |
Frequently Asked Questions
What does Chenrezig Fund Inc do?โผ
Chenrezig Fund Inc is a international, foreign affairs & national security nonprofit organization based in Wisconsin. It is classified under NTEE code Q127 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Chenrezig Fund Inc financially healthy?โผ
Financial health scoring requires Form 990 filing data. Check back as we process more filings for Chenrezig Fund Inc.
How much revenue does Chenrezig Fund Inc generate?โผ
Chenrezig Fund Inc reports $185K in annual revenue and holds $75K in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the International, Foreign Affairs & National Security category, or browse all nonprofits in Wisconsin.